Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs for Postoperative Pain Following Elective Lumbar Spine Fusion
NCT07743606Phase 3Enrolling by invitation
- Sponsor
- Rothman Orthopaedics
- Start
- Jul 2024
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketorolac and naproxen in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Revision surgery for symptomatic lumbar spinal fusion nonunion at 2 years. Started Jul 2024; status: enrolling by invitation.
02
Drugs
ketorolacnaproxen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07743606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743606.